Life Sciences and Diagnostics Markets — Net revenue
Agilent Technologies Life Sciences and Diagnostics Markets — Net revenue decreased by 10.1% to $679.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 4.9%, from $647.00M to $679.00M. Over 2 years (FY 2023 to FY 2025), Life Sciences and Diagnostics Markets — Net revenue shows relatively stable performance with a -1.0% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates growing market share or higher demand for the segment's product portfolio, while a decrease may signal competitive pressure or market saturation.
Detailed definition
This represents the total gross sales generated by the Life Sciences and Diagnostics business segment after deducting re...
Peer comparison
Standard revenue reporting for life science tool manufacturers, comparable to peers in the diagnostics and analytical instrumentation space.
a_segment_life_sciences_and_diagnostics_markets_net_revenueHistorical Data
| Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $695.00M | $695.00M | $695.00M | $695.00M | $620.00M | $604.00M | $585.00M | $657.00M | $647.00M | $654.00M | $670.00M | $755.00M | $679.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -10.8% | -2.6% | -3.1% | +12.3% | -1.5% | +1.1% | +2.4% | +12.7% | -10.1% |
| YoY Change | — | — | — | — | -10.8% | -13.1% | -15.8% | -5.5% | +4.4% | +8.3% | +14.5% | +14.9% | +4.9% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Agilent Technologies's life sciences and diagnostics markets — net revenue?
- Agilent Technologies (A) reported life sciences and diagnostics markets — net revenue of $679.00M in Q4 2025.
- How has Agilent Technologies's life sciences and diagnostics markets — net revenue changed year-over-year?
- Agilent Technologies's life sciences and diagnostics markets — net revenue increased by 4.9% year-over-year, from $647.00M to $679.00M.
- What is the long-term trend for Agilent Technologies's life sciences and diagnostics markets — net revenue?
- Over 2 years (2023 to 2025), Agilent Technologies's life sciences and diagnostics markets — net revenue has grown at a -1.0% compound annual growth rate (CAGR), from $2.78B to $2.73B.
- What does life sciences and diagnostics markets — net revenue mean?
- The total amount of money generated from sales within the Life Sciences and Diagnostics business segment.